Perry Daniel, Sang Allison, Yin Yiming, Zheng Ying-Yi, Morel Laurence
Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL 32610, USA.
J Biomed Biotechnol. 2011;2011:271694. doi: 10.1155/2011/271694. Epub 2011 Feb 14.
Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disorder. The study of diverse mouse models of lupus has provided clues to the etiology of SLE. Spontaneous mouse models of lupus have led to identification of numerous susceptibility loci from which several candidate genes have emerged. Meanwhile, induced models of lupus have provided insight into the role of environmental factors in lupus pathogenesis as well as provided a better understanding of cellular mechanisms involved in the onset and progression of disease. The SLE-like phenotypes present in these models have also served to screen numerous potential SLE therapies. Due to the complex nature of SLE, it is necessary to understand the effect specific targeted therapies have on immune homeostasis. Furthermore, knowledge gained from mouse models will provide novel therapy targets for the treatment of SLE.
J Biomed Biotechnol. 2011
Am J Pharmacogenomics. 2002
Autoimmun Rev. 2004-1
Curr Rheumatol Rep. 2002-8
Curr Rheumatol Rep. 2001-6
Environ Health Perspect. 1999-10
Semin Nephrol. 1999-1
Arthritis Res. 2002
Diagnostics (Basel). 2024-12-12
World J Pediatr. 2024-12
Biol Sex Differ. 2024-10-7
Int J Mol Sci. 2024-9-14
Lupus Sci Med. 2024-6-21
Proc Natl Acad Sci U S A. 2010-8-23
Autoimmun Rev. 2010-7-23
Autoimmun Rev. 2010-7-24
Nat Rev Rheumatol. 2010-7-20